The species-specific GSDMD cleavage also suggested that a humanized animal or human GSDMD transgenic mouse rather than a simple murine GBM model would provide convincing experimental conclusions of preclinical ZIKV oncotherapy. This evidence concerns the gene GSDMD and glioblastoma.